Analysis of Cutaneous Phosphorylated Alpha-Synuclein to Identify Patients at Risk of Progressing From Essential Tremor to Parkinson's Disease

Recruiting

Syn-One TestAnalysis of Cutaneous Phosphorylated Alpha-Synuclein to Identify Patients at Risk of Progressing From Essential Tremor to Parkinson's Disease

Sponsor:

CND Life Sciences

Code:

NCT07428447

Conditions

Essential Tremor, Movement Disorders

Essential Tremor

Essential Tremor-plus

Eligibility Criteria

Sex: All

Age: 50 - 70+

Healthy Volunteers: Not accepted

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-04-11. This information was provided to ClinicalTrials.gov by CND Life Sciences on 2026-02-23.